about
Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.The Multidimensional Prognostic Index (MPI), based on a comprehensive geriatric assessment predicts short- and long-term mortality in hospitalized older patients with dementia.Association of apolipoprotein E and angiotensin converting enzyme gene polymorphisms with the multidimensional impairment in older patients.Apolipoprotein E-related all-cause mortality in hospitalized elderly patients.The multidimensional prognostic index predicts short- and long-term mortality in hospitalized geriatric patients with pneumoniaFOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer's disease.Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene.Angiotensin-converting enzyme (ACE) genotypes and disability in hospitalized older patientsKlotho locus, metabolic traits, and serum hemoglobin in hospitalized older patients: a genetic association analysis.The Comprehensive Geriatric Assessment and the multidimensional approach. A new look at the older patient with gastroenterological disorders.Validation of a Modified-Multidimensional Prognostic Index (m-MPI) including the Mini Nutritional Assessment Short-Form (MNA-SF) for the prediction of one-year mortality in hospitalized elderly patientsPotential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease.A Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short- and long-term all-cause mortality in older hospitalized patients with transient ischemic attack.Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease.Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms.Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease.Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option?Anti-β-amyloid immunotherapy for Alzheimer's disease: focus on bapineuzumab.Mediterranean diet in predementia and dementia syndromes.Metabolic syndrome, mild cognitive impairment, and dementia.Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease.The genetics of the human APOE polymorphism.Different models of frailty in predementia and dementia syndromes.Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.Pharmacogenetics in older people: what we know and what we need to know.Acetylcholinesterase inhibitors are associated with weight loss in older people with dementia: a systematic review and meta-analysis.Information and Communication Technologies for the Activities of Daily Living in Older Patients with Dementia: A Systematic Review.Neuroprotective Effects of Quercetin: From Chemistry to Medicine.Daidzein and its Effects on Brain.Phytochemicals in the Treatment of Alzheimer's Disease: A Systematic Review.Sexual dimorphism of frailty and cognitive impairment: Potential underlying mechanisms (Review).Emerging biomarkers and screening for cognitive frailty.Robotic and Sensor Technologies for Mobility in Older People.Delusions in Patients with Alzheimer's Disease: A Multidimensional Approach.Alzheimer's Disease and Cognitive Frailty: Novel Therapeutic Technologies.Polymorphism C in the serotonin transporter gene in depression-free elderly patients with vascular dementia.Information and communication technology systems to improve quality of life and safety of Alzheimer's disease patients: a multicenter international survey.Apigenin as neuroprotective agent: Of mice and men.The serotonin transporter gene locus in late-life major depressive disorder.
P50
Q31096423-28BF5996-0A55-48C4-8CC8-18A9735CB8EEQ33829496-F9BB8017-9639-4C85-AC05-DB3C43C9F67FQ33844606-BE94A97D-23F8-440E-9B9A-16C32810A668Q34080448-890A606A-C056-4ACB-9EE9-D95ADA32E546Q34310465-7146A2F8-720C-42C6-853D-B7312A53EC3BQ34415342-A88B175F-5C4D-4B70-875A-8F246D9E3A26Q34953672-E2B898ED-E568-4816-817D-2EA3EE406D95Q35201107-63738DCE-EDF0-49DB-B6AD-BBA18445AFB2Q36927446-48FD47C0-1432-4B18-82A0-D2D667408697Q37179227-F69DAF34-2DED-4DE5-9A25-1F341D0BCBFCQ37214075-D691AFDF-9A0E-495A-9ECB-D3E956B1EE93Q37297626-9E29179A-A8D0-4A34-89F1-00FD091F4A54Q37337050-99089F90-2654-4377-8B42-D48ADBC4F5FCQ37429026-9C23C8C0-D4FD-490C-ADFE-6D9EB392F492Q37507831-D0602697-FD94-4D18-9B32-DB969A580F69Q37767097-61C83BF1-12B8-4AEC-B82C-D69FB804F7D7Q37810956-62FDBDB5-D287-4B3D-BDC8-0932A88415DCQ37827490-57BDE610-D485-4815-A68F-703E5D9137DAQ37876922-81BCEADB-EC14-4245-8F10-F6170EC8D2AEQ37878519-3C704182-E632-4032-BA2E-F26B6536AA28Q37878520-0F17C223-0D32-48C1-AE5F-837891421E5EQ37901817-53635592-F842-4167-95F2-962BBFF33362Q37940538-58BD0F5C-55BC-4986-A128-F4D839ECE235Q37942041-2B5777E5-8709-486F-9A61-9157F65D707FQ37999086-784D201B-8126-4D64-87CB-B045366BB7F5Q38000090-15E71076-DF16-4BED-8DFB-7245F06BEDF8Q38853967-649ED1ED-5BC1-4CA0-B83D-CCB3B4AB69EAQ38901557-3770B782-7521-4385-B108-33A34BDD2E8DQ38928545-978EDE4B-44B8-4B12-9F3D-9593EED250D3Q38996538-6E97266E-EDFC-42AD-9CE5-14B6B1763809Q38997533-3AE743F6-1F22-4A5B-8624-4CD2D49C70E0Q39152778-A2CCAC6F-4FBC-4BD4-82AA-875E77D0BB72Q39161884-BC0552CF-51AE-4F35-9349-271BF018BB3EQ39291341-E5F9225B-0961-4CB5-8D1A-8776EBDE55FAQ40902363-12C07A6E-BED8-400F-B394-876226224749Q42375921-EA21880F-C9C8-434C-91FD-87E4753C34ADQ43054495-7C938680-9861-4C36-883B-3EA21A421170Q46270309-74AAD39A-8CB3-4B14-BF0D-EAAA7123EF95Q46278430-5B527D48-B0DE-49A5-A985-6C6537FF3FCEQ46352962-7687C80B-01FA-459A-9DEF-F758409F20A9
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Grazia D'Onofrio
@ast
Grazia D'Onofrio
@en
Grazia D'Onofrio
@es
Grazia D'Onofrio
@nl
Grazia D'Onofrio
@sl
type
label
Grazia D'Onofrio
@ast
Grazia D'Onofrio
@en
Grazia D'Onofrio
@es
Grazia D'Onofrio
@nl
Grazia D'Onofrio
@sl
prefLabel
Grazia D'Onofrio
@ast
Grazia D'Onofrio
@en
Grazia D'Onofrio
@es
Grazia D'Onofrio
@nl
Grazia D'Onofrio
@sl
P1053
K-9740-2016
P106
P1153
24178902200
P21
P31
P3829
P496
0000-0002-5905-6063